0001628280-23-042253.txt : 20231220 0001628280-23-042253.hdr.sgml : 20231220 20231220163812 ACCESSION NUMBER: 0001628280-23-042253 CONFORMED SUBMISSION TYPE: AW PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20231220 DATE AS OF CHANGE: 20231220 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Fresh Tracks Therapeutics, Inc. CENTRAL INDEX KEY: 0000819050 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 930948554 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: AW SEC ACT: SEC FILE NUMBER: 333-236757 FILM NUMBER: 231501770 BUSINESS ADDRESS: STREET 1: 5777 CENTRAL AVENUE STREET 2: SUITE 102 CITY: BOULDER STATE: CO ZIP: 80301 BUSINESS PHONE: (720) 505-4755 MAIL ADDRESS: STREET 1: 5777 CENTRAL AVENUE STREET 2: SUITE 102 CITY: BOULDER STATE: CO ZIP: 80301 FORMER COMPANY: FORMER CONFORMED NAME: Brickell Biotech, Inc. DATE OF NAME CHANGE: 20190830 FORMER COMPANY: FORMER CONFORMED NAME: VICAL INC DATE OF NAME CHANGE: 19940211 AW 1 a20231220aws3.htm AW Document

FRESH TRACKS THERAPEUTICS, INC.
2000 Central Avenue, Suite 100
Boulder, Colorado 80301
December 20, 2023

VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549

RE:    Fresh Tracks Therapeutics, Inc.
Withdrawal of Post-Effective Amendment No. 1 to Form S-3 Registration Statement
File No. 333-236757
Ladies and Gentlemen:

Pursuant to Rule 477 promulgated under the Securities Act of 1933, as amended, Fresh Tracks Therapeutics, Inc. (the “Registrant”) hereby respectfully requests that the U.S. Securities and Exchange Commission (the “Commission”) consent to the withdrawal, effective as of the date hereof or at the earliest practicable date hereafter, of the Registrant’s Post-Effective Amendment No. 1 (the “Amendment”) to its Registration Statement on Form S-3 (File No. 333-236757) (the “Registration Statement”). The Registration Statement was initially filed with the Commission on February 28, 2020 and was declared effective by the Commission on March 19, 2020. The Amendment was filed with the Commission on December 19, 2023. The Amendment was inadvertently filed in the Commission’s Electronic Data Gathering and Retrieval system as form type “S-3/A” rather than form type “POS AM.” The Registrant intends to file a revised Amendment solely to rectify this EDGAR form type error.

The Registrant confirms that the Amendment was not declared effective, and no securities were issued in connection with the Amendment.

Should you have any questions regarding this request, please do not hesitate to contact counsel to the Registrant, Jonathan R. Zimmerman of Faegre Drinker Biddle & Reath LLP at (612) 766-8419, or in his absence, Griffin D. Foster at (317) 569-4843.

Sincerely,

FRESH TRACKS THERAPEUTICS, INC.


By: /s/ Albert N. Marchio, II
Name: Albert N. Marchio, II
Title: Chief Executive Officer and Chief Financial Officer


cc:    Jonathan R. Zimmerman, Faegre Drinker Biddle & Reath LLP
    Griffin D. Foster, Faegre Drinker Biddle & Reath LLP